Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?

European Journal of Internal Medicine

Volumn 23, Issue 6, 2012, Pages

  Morace, C ^a   Cucunato, M ^a   Bellerone, R ^a   De Caro, G ^b   Crino S ^a   Fortiguerra, A ^a   Spadaro, F ^c   Zirilli, A ^c   Alibrandi, A ^c   Consolo, P ^a   Luigiano, C ^d   Resta, M L ^a   Ferrau O ^a   Spadaro, A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Servizio di Endoscopia Digestiva   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d BELLARIA HOSPITAL   (Italy)

Author keywords

Alpha fetoprotein; Diagnosis; Hepatocellular carcinoma; Insulin like growth factor II; Liver cirrhosis

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; SOMATOMEDIN B; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERUM; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84864633961     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.04.014     Document Type: Article

References (65)

1. M. Colombo Malignant neoplasm of the liver E.R. Schiff, M.F. Sorrel, W.C. Maddrey, Schiff's Disease of the Liver 9th ed 2003 Lippincott William & Wilkins Philadelphia 1377 1404
2. J.-G. Scharf, F. Dombrowski, and G. Ramadori The IGF axis and hepatocarcinogenesis J Clin Pathol Mol Pathol 54 2001 138 144 (Pubitemid 32539603)
3. C.J. Chen, M.W. Yu, and Y.F. Liaw Epidemiological characteristics and risk factors of hepatocellular carcinoma J Gastroenterol Hepatol 12 1997 S294 S308
4. H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750 (Pubitemid 29114292)
5. M. Colombo, R. De Franchis, E. Del Ninno, A. Sangiovanni, C. De Fazio, and M. Tommasini Hepatocellular carcinoma in Italian patients with cirrhosis N Engl J Med 325 1991 675 680
6. C.W. Boone, G.J. Kelloff, and V.E. Steele Natural history of intraepithelial neoplasia in humans with implications for cancer chemopreventive strategy Cancer Res 52 1992 1651 1659
7. H.C. Pitot The molecular biology of carcinogenesis Cancer 72 1993 962 970 (Pubitemid 23218011)
8. B. Vogelstein, and K.W. Kinzler The multistep nature of cancer Trends Genet 9 1993 138 141 (Pubitemid 23098782)
9. Y.P. Dragan, and H.C. Pitot The role of the stages of initiation and promotion in phenotypic diversity during hepatocarcinogenesis in the rat Carcinogenesis 13 1992 739 750
10. T.L. Goldsworthy, M.H. Hanigan, and H.C. Pitot Model of hepatocarcinogenesis in the rat - contrasts and comparisons CRC Crit Rev Toxicol 17 1986 61 89
11. K.D. Hanson, M. Shichiri, M.R. Follansbee, and J.M. Sedivy Effects of c-myc expression on cell cycle progression Mol Cell Biol 14 1994 5748 5755 (Pubitemid 24264403)
12. P. Nagy, R.P. Evarts, E. Marsden, J. Roach, and S.S. Thorgeirsson Cellular distribution of c-Myc transcript during chemical hepatocarcinogenesis in rats Cancer Res 48 1988 5522 5527
13. G.J. Cote, B.A. Lastra, J.R. Cook, D.P. Huang, and J.F. Chiu Oncogene expression in rat hepatomas and during hepatocarcinogenesis Cancer Lett 26 1985 121 127 (Pubitemid 15139649)
14. D.G. Beer, M. Schwarz, N. Sawada, and H.C. Pitot Expression of H-ras and c-myc proto-oncogens in isolated gamma-glutamyl transpeptidase-positive rat hepatocytes and in hepatocellular carcinomas induced by diethylnitrosamine Cancer 46 1986 2435 2441 (Pubitemid 16120710)
15. B. Grasl-Kraupp, W. Bursch, B. Ruttkay-Nedecky, A. Wagner, B. Lauer, and R. Schulte-Hermann Food restriction eliminates preneoplastic cell through apoptosis and antagonizes carcinogenesis in rat liver Proc Natl Acad Sci U S A 91 1994 9995 9999 (Pubitemid 24311935)
16. N. Fausto Growth factors in liver development, regeneration and carcinogenesis Prog Growth Factor Res 3 1991 219 234 (Pubitemid 121006996)
17. D. Yang, E. Alt, and C.E. Rogler Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers Cancer Res 53 1993 2020 2027 (Pubitemid 23145720)
18. Isabel Zvibel, Shlomo Brill, and Lola M. Reid Insulin-like growth factor II regulation of gene expression in rat and human hepatomas J Cell Physiol 162 1995 36 43
19. E.M. Webber, M.J. FitzGerald, P.I. Brown, M.H. Bartlett, and N. Fausto Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor Hepatology 18 1993 1422 1431
20. S.E. Kern, J.A. Pietenpol, S. Thiagalingam, A. Seymour, K.W. Kinzler, and B. Vogelstein Oncogenetic forms of p53 inhibit p53-regualted gene expression Science 256 1992 827 830
21. B. Bressac, K.M. Galvin, T.J. Liang, K.J. Isselbacher, J.R. Wands, and M. Ozturk Abnormal structure and expression of p53 gene in human hepatocellular carcinoma Proc Natl Acad Sci U S A 87 1990 1973 1977
22. M. Chiaramonte, T. Stroffolini, A. Vian, M.A. Stazi, A. Floreani, and U. Lorenzoni Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis Cancer 85 1999 2132 2137 (Pubitemid 29215551)
23. F. Donato, P. Boffetta, and M. Puoti A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma Int J Cancer 75 1998 347 354 (Pubitemid 28100034)
24. L. Solmi, A.M.M. Primerano, and L. Gandolfi Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases Am J Gastroenterol 91 1996 1189 1194 (Pubitemid 26175481)
25. M. Zoli, D. Magalotti, G. Bianchi, C. Gueli, G. Marchesini, and E. Pisi Efficacy of a surveillance program for early detection of hepatocellular carcinoma Cancer 78 1996 977 985 (Pubitemid 26284861)
26. M. Unoura, S. Kaneko, E. Matsushita, A. Shimoda, M. Takeuchi, and H. Adachi High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease Hepatogastroenterology 40 1993 305 310 (Pubitemid 23258544)
27. M. Cottone, M. Turri, M. Caltagirone, P. Parisi, A. Orlando, and G. Fiorentino Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein J Hepatol 21 1994 1029 1034
28. J.F. Tsai, J.E. Jeng, M.S. Ho, W.Y. Chang, Z.Y. Lin, and J.H. Tsai Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma Br J Cancer 72 1995 442 446
29. D.S. Chen, J.L. Sung, J.C. Sheu, M.Y. Lai, S.W. How, and H.C. Hsu Serum α-fetoprotein in the early stage of human hepatocellular carcinoma Gastroenterology 86 1984 1404 1409 (Pubitemid 14147930)
30. H. Oka, A. Tamori, T. Kuroki, K. Kobayashi, and S. Yamamoto Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma Hepatology 19 1994 61 66
31. M. Capurro, I.R. Wanless, M. Sherman, G. Deboer, W. Shi, and E. Miyoshi Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma Gastroenterology 125 2003 89 97 (Pubitemid 36799110)
32. Y. Aoyagi, M. Oguro, M. Yanagi, Y. Mita, T. Suda, and Y. Suzuki Clinical significance of simultaneous determination of alpha-fetoprotein and des-gamma carboxyprothrombin in monitoring recurrence in patients with hepatocellular carcinoma Cancer 77 1996 1781 1786 (Pubitemid 26125176)
33. Y. Mita Aoyagi, M. Yanagi, T. Suda, Y. Suzuki, and H. Asakura The usefulness of determining des-gamma carboxyprothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma Cancer 82 1998 1643 1648 (Pubitemid 28208912)
34. F. Nomura, M. Ishijima, K. Kuwa, N. Tanaka, T. Nakai, and K. Ohnishi Serum des-gamma carboxyprothrombin levels determined by a new generation of sensitive immunoassay in patient with small sized hepatocellular carcinoma Am J Gastroenterol 94 1999 650 654 (Pubitemid 29124861)
35. H. Yamagami, M. Moriyama, N. Tanaka, and Y. Arakawa Detection of serum and intrahepatic human hepatocyte growth factor in patients with type C liver disease Intervirology 44 2001 36 42 (Pubitemid 32172942)
36. G. Mazzioti, F. Sorvillo, F. Morisco, A. Carbone, M. Rotondi, and G. Stornaiuolo Serum insulin-like growth factor-1 evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patient with hepatitis c virus-related cirrhosis Cancer 95 2002 2539 2545 (Pubitemid 35424040)
37. A. Spadaro, A. Ajello, C. Morace, A. Zirilli, G. D'arrigo, and C. Luigiano Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits World J Gastroenterol 11 2005 1987 1990 (Pubitemid 40520997)
38. A. Spadaro, A. Ajello, C. Luigiano, C. Morace, M.L. Resta, and G. Berlinghieri Low utility of plasma nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma World J Gastroenterol 12 2006 4716 4720 (Pubitemid 44269733)
39. K. Breuhahn, T. Longerich, and P. Schirmacher Dysregulation of growth factor signaling in human hepatocellular carcinoma Oncogene 25 2006 3787 3800 (Pubitemid 43980474)
40. F. Wilkin, N. Gagne, J. Paquette, L.L. Oligny, and C. Deal Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression J Clin Endocrinol Metab 85 2000 2048 2056 (Pubitemid 32269319)
41. J.G. Scharf, F. Dombrowski, and G. Ramadori The IGF axis and hepatocarcinogenesis Mol Pathol 54 2001 138 144 (Pubitemid 32539603)
42. Z.R. Fan, D.H. Yang, J. Cui, H.R. Qin, and C.C. Huang Expression of insulin like growth factors II and its receptor in hepatocellular carcinogenesis World J Gastroenterol 7 2001 285 288 (Pubitemid 32377486)
43. Z. Wang, Y.B. Ruan, Y. Guan, and S.H. Liu Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis World J Gastroenterol 9 2003 267 270 (Pubitemid 36215801)
44. E. Cariani, C. Lasserre, D. Seurin, B. Hamelin, F. Kemeny, and D. Franco Differential expression of insulin like growth factor II mRNA in human primary liver cancers, benign liver tumours, and liver cirrhosis Cancer Res 48 1988 6844 6849 (Pubitemid 19012216)
45. H. Yu, and T. Rohan Role of the insulin like growth factor family in cancer development and progression J Natl Cancer Inst 92 2000 1472 1489
46. P.Y. Chen, and P.M. Popovich Correlation: Parametric and Nonparametric Measures 2002 Sage Publication Thousand Oaks, CA
47. F. Pesarin Multivariate Permutation Tests: With Application in Biostatistic 2001 John Wiley & Sons, LTD Chichester, New York, Weinheim, Brisbane, Singapore, Toronto
48. Henderson AR. Medical Decision Making. Sox HC, Blatt MA, Higgins MC, Marton KI. Boston: Butterworths 1988, Clin Chem 1989 35: 2020-2021.
49. M.H. Zweig, and G. Campbell Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine Clin Chem 39 1993 561 577 (Pubitemid 23118304)
50. L. Benvegnu, M. Gios, S. Boccato, and A. Alberti Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications Gut 53 2004 744 749 (Pubitemid 38561455)
51. M. Soresi, C. Magliarisi, P. Campagna, G. Leto, G. Bonfissuto, and A. Riili Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma Anticancer Res 23 2003 1747 1753 (Pubitemid 36750842)
52. J. Zhang, and E.K. Chan Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinoma Autoimmun Rev 1 2002 146 153 (Pubitemid 38340265)
53. H. Huynh, P.K. Chow, L.L. Ooi, and K.C. Soo A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation Cell Growth Differ 13 2002 115 122 (Pubitemid 34507101)
54. N. Zhang, K. Siegel, M. Odenthal, R. Becker, F. Oesch, and H.P. Dienes The role of insulin-like growth factor II in the malignant transformation of rat liver oval cells Hepatology 25 1997 900 905 (Pubitemid 27157132)
55. Q. Su, Y.F. Liu, J.F. Zhang, S.X. Zhang, D.F. Li, and J.J. Yang Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression Hepatology 20 1994 788 799 (Pubitemid 24296482)
56. J.G. Scharf, G. Ramadori, and F. Dombrowski Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats Lab Invest 80 2000 1399 1411
57. J.J. Su, G.Z. Qin, R.Q. Yan, D.R. Huang, C. Yang, and P.D. Lotlikar The expression of insulin-like growth factor II, hepatitis B virus X antigen and p21 in experimental hepatocarcinogenesis in tree shrews Ann Acad Med Singapore 28 1999 62 66
58. H.M. Khandwala, I.E. McCutcheon, A. Flyvbjerg, and K.E. Friend The effects of insulin-like growth factors on tumorigenesis and neoplastic growth Endocr Rev 21 2000 215 244 (Pubitemid 32275588)
59. D.R. Clemmons Insulin-like growth factor binding proteins and their role in controlling IGF actions Cytokine Growth Factor Rev 8 1997 45 62 (Pubitemid 27214688)
60. S. Aishima, Y. Basaki, Y. Oda, Y. Kuroda, Y. Nishihara, and K. Taguchi High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma Cancer Sci 97 2006 1182 1190 (Pubitemid 44437362)
61. M.H. Bae, M.J. Lee, S.K. Bae, O.H. Lee, Y.M. Lee, and B.C. Park Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity Cancer Lett 128 1998 41 46 (Pubitemid 28279363)
62. Z.Z. Dong, D.F. Yao, D.B. Yao, X.H. Wu, W. Wu, and L.W. Qiu Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma World J Gastroenterol 11 2005 4655 4660 (Pubitemid 41179518)
63. J.F. Tsai, J.E. Jeng, L.Y. Chuang, H.L. You, M.S. Ho, and C.S. Lai Serum insulin-like growth factor II and alphafetoprotein as tumour markers of hepatocellular Tumour Biol 24 2003 291 298 (Pubitemid 38327991)
64. J.F. Tsai, J.E. Jeng, L.Y. Chuang, H.L. You, L.Y. Wang, and M.Y. Hsieh Serum insulin-like growth factor II as a serologic marker of small hepatocellular carcinoma Scand J Gastroenterol 40 2005 68 75
65. K.W. Kim, S.K. Bae, O.H. Lee, M.H. Bae, M.J. Lee, and B.C. Park Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma Cancer Res 58 1998 348 351 (Pubitemid 28047078)